COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Lennard-Jones Centre > Pre-training Molecular Graph Representation with 3D Geometry
Pre-training Molecular Graph Representation with 3D GeometryAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Dr Christoph Schran. Molecular graph representation learning is a fundamental problem in modern drug and material discovery. Molecular graphs are typically modeled by their 2D topological structures, but it has been recently discovered that 3D geometric information plays a more vital role in predicting molecular functionalities. However, the lack of 3D information in real-world scenarios has significantly impeded the learning of geometric graph representation. To cope with this challenge, we propose the Graph Multi-View Pre-training (GraphMVP) framework where self-supervised learning (SSL) is performed by leveraging the correspondence and consistency between 2D topological structures and 3D geometric views. GraphMVP effectively learns a 2D molecular graph encoder that is enhanced by richer and more discriminative 3D geometry. We further provide theoretical insights to justify the effectiveness of GraphMVP. Finally, comprehensive experiments show that GraphMVP can consistently outperform existing graph SSL methods. This talk is part of the Lennard-Jones Centre series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsHorizon: Bioengineering Department of Archaeology - Garrod seminar series St Catharine's College LecturesOther talksA touch of non-linearity: mesoscale swimmers and active matter in fluids Oral Session 4 Modulation theory in two-component Bose-Einstein condensates: the ferromagnetic paradigm Welcome and Introduction Deciphering Shared Intratumor Transcriptional Heterogeneity of Human Tumors A Landmarking Approach for the Dynamic Scheduling of Cardiovascular Risk Assessments |